STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Q-Med (STO:QMED):
• Group revenues from sales of goods and royalties amounted to 981.7 (972.2) MSEK during the period.
• Growth within the Esthetics product area was 18 percent and revenues amounted to 800.4 (680.3) MSEK.
• Operating income amounted to 381.2 (259.2) MSEK and the operating margin was 39 (29) percent.
• Income after tax amounted to 329.1 (186.7) MSEK.
• Earnings per share after full dilution were 3.31 (1.88) SEK.
